May 26, 2018 2:52 PM ET


Company Overview of Salient Pharmaceuticals Incorporated

Company Overview

Salient Pharmaceuticals Incorporated engages in the development of a drug compound for the treatment of multiple inflammatory gastrointestinal (GI) conditions. It is developing CASAD, a drug for the treatment of cancer therapy-induced diarrhea, chronic conditions, infectious diseases, drug-related causes, and radiation therapy. The company was founded in 2007 and is based in Houston, Texas.

2429 Bissonnet

Suite 383

Houston, TX 77005

United States

Founded in 2007





Key Executives for Salient Pharmaceuticals Incorporated

Chief Executive Officer, President and Director
Age: 61
Medical Director and Member of Scientific Advisory Board
Director of Quality
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
Praetego, Inc. United States
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Salient Pharmaceuticals Incorporated, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at